SCHEMBL2660108

SCHEMBL2660108

Cc1nsc(-c2cccc(C(N)=O)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.47
MAP2K4 P45985 1/20 0.47
PDE4D Q08499 2/20 0.45
PDE7A Q13946 1/20 0.45
DYRK1A Q13627 1/20 0.44
HSD17B1 P14061 2/20 0.44
HSD17B2 P37059 2/20 0.44
PDE2A O00408 1/20 0.44
PDE3A Q14432 1/20 0.44
PDE10A Q9Y233 1/20 0.44
CCNT1 O60563 1/20 0.43
CCND1 P24385 1/20 0.43
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
CDK7 P50613 1/20 0.43
CDK9 P50750 1/20 0.43
CCNH P51946 1/20 0.43
MNAT1 P51948 1/20 0.43
CDK6 Q00534 1/20 0.43
BAZ2B Q9UIF8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14873296 0.76 HSD17B1 (0.58) HSD17B1HSD17B2NPC1RAB9A
SCHEMBL30957406 0.76 HSD17B1 (0.68) HSD17B1HSD17B2RAB9A
SCHEMBL12266907 0.76 MEN1 (0.49) HSD17B1HSD17B2NPC1RAB9A
SCHEMBL19152881 0.75 KDM4E (0.47) PDE4DPDE7AHSD17B1HSD17B2PDE3A
SCHEMBL14873352 0.75 HSD17B1 (0.61) HSD17B1HSD17B2RAB9A
SCHEMBL3882303 0.75 PARP1 (0.49) PARP1MAP2K4PDE4DPDE7AHSD17B1
SCHEMBL29441126 0.73 FYN (0.49) PARP1MAP2K4PDE4DPDE7AHSD17B1
SCHEMBL28322519 0.73 FYN (0.49) PARP1MAP2K4PDE4DPDE7AHSD17B1
SCHEMBL7369335 0.73 CYP19A1 (0.56) HSD17B1HSD17B2NPC1RAB9A
SCHEMBL2431097 0.73 PARP1 (0.64) PARP1CCNT1CCND1CCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902052-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES AstraZeneca AB (SE) 2008-03-26 EP disclosed
WO-2007007041-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2007-01-18 WO disclosed